DFTX – definium therapeutics, inc. - common shares (US:NASDAQ)
Stock Stats
News
Definium Therapeutics (DFTX) had its price target raised by HC Wainwright from $55.00 to $70.00. They now have a "buy" rating on the stock.
Definium Therapeutics Weighs Breakthrough Status Against Valuation And Trial Risks [Yahoo! Finance]
Definium Therapeutics Q4 Earnings Call Highlights [Yahoo! Finance]
Definium Therapeutics Reports Full-Year 2025 Financial Results and Business Updates [Yahoo! Finance]
Definium Therapeutics Reports Full-Year 2025 Financial Results and Business Updates
Form 10-K Definium Therapeutics, For: Dec 31
Form 8-K Definium Therapeutics, For: Feb 26
Form SCHEDULE 13G/A Definium Therapeutics, Filed by: Commodore Capital LP
Form SCHEDULE 13G Definium Therapeutics, Filed by: DRIEHAUS CAPITAL MANAGEMENT LLC
Form SCHEDULE 13G Definium Therapeutics, Filed by: Avoro Capital Advisors LLC
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.